CD44 and breast cancer: We first determined the expression of CD44, iASPP, and p53 by immunoblotting of cell lysates from normal and transformed cells of both mesenchymal and epithelial origin, including AG1523 fibroblasts, immortalized hTERT-BJ fibroblasts, immortalized normal mammary epithelial cells MCF10A, metastatic breast cancer cells MCF-7, HEK293 cells, non-small cell lung carcinoma cells H1299, osteosarcoma U2OS, primary dermal fibroblasts MTS64, and hepatocellular HepG2 cells (Figure 1).